CTX-M beta-lactamase production and virulence of Escherichia coli K1

Damien Dubois1, Nemani V Prasadarao, Rahul Mittal

  • 1University of Auvergne, Clermont-Ferrand F-63001, France.

Insights

Neonatal meningitis caused by Escherichia coli K1 was studied. CTX-M-1 production did not affect bacterial virulence but significantly impacted patient outcomes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Neonatal Health

Background:

  • Neonatal meningitis poses a significant threat to infant health.
  • Escherichia coli K1 is a common cause of bacterial meningitis in newborns.
  • CTX-M-1 is a type of beta-lactamase enzyme conferring antibiotic resistance.

Observation:

  • A case of neonatal meningitis was identified, caused by a CTX-M-1-producing Escherichia coli K1 strain.
  • The study investigated the role of CTX-M-1 production in bacterial virulence.
  • Experiments were conducted using cell cultures and a newborn mouse model of meningitis.

Findings:

  • CTX-M-1 production did not influence the virulence of the Escherichia coli K1 strain in vitro or in vivo.
  • Despite no change in virulence, CTX-M-1 production was a major determinant of the clinical outcome in the patient.
  • This suggests that antibiotic resistance mechanisms can disproportionately affect clinical prognosis.

Implications:

  • The findings highlight the complex relationship between antibiotic resistance and bacterial pathogenesis.
  • Understanding the impact of resistance genes on clinical outcomes is crucial for effective treatment strategies in neonatal meningitis.
  • Further research is warranted to elucidate the mechanisms by which CTX-M-1 production influences clinical outcomes beyond direct virulence.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...